Ebitda تغيير تاريخ
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Celltrion KRW 25.72B 6.08B 2026-06
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -61.38M 14.92M 2026-06
Divis Laboratories Ltd INR 15.66B 3.04B 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
Glaxosmithkline GBP 2.93B 154M 2026-09
Kangmei Pharma CNY -12.72M 30.02M 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Merck USD 1.42B 2.97B 2026-06
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Novartis USD 5.36B 45M 2026-09
Organigram Holdings CAD 15.45M 20.21M 2026-06
Organon & Co USD 502M 131M 2026-09
Pharma Mar EUR 9.63M 8.93M 2026-09
Qiagen NV USD 219.78M 12.13M 2026-09
Sartorius EUR 279.9M 600K 2026-09
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Tilray USD 8.36M 1.82M 2025-09
Zealand Pharma A/S -379M 348.47M 2026-03